Nalepa I, Vetulani J
J Psychiatry Neurosci. 1994; 19(2):120-8.
PMID: 8204564
PMC: 1188576.
Sansone M
Psychopharmacology (Berl). 1982; 78(1):54-7.
PMID: 6815697
DOI: 10.1007/BF00470588.
HANO J, Vetulani J, Sansone M, Oliverio A
Psychopharmacology (Berl). 1981; 73(3):265-8.
PMID: 6787647
DOI: 10.1007/BF00422415.
Turski L, Czuczwar S, TURSKI W, Kleinrok Z
Psychopharmacology (Berl). 1981; 73(1):81-3.
PMID: 6785795
DOI: 10.1007/BF00431107.
MALEC D, LANGWINSKI R
Psychopharmacology (Berl). 1980; 69(1):79-83.
PMID: 6771831
DOI: 10.1007/BF00426526.
Acute and chronic effects of serotonin (5HT) antagonists on serotonin binding sites.
Blackshear M, Friedman R, Sanders-Bush E
Naunyn Schmiedebergs Arch Pharmacol. 1983; 324(2):125-9.
PMID: 6646240
DOI: 10.1007/BF00497017.
Evidence against the involvement of serotonergic mechanisms in wet dog shake behavior induced by carbachol chloride in rats.
Turski L, TURSKI W, Czuczwar S, Kleinrok Z
Psychopharmacology (Berl). 1981; 73(4):376-80.
PMID: 6454900
DOI: 10.1007/BF00426469.
The role of the serotonergic system in foot shock-induced behavior in mice.
Rolinski Z, Herbut M
Psychopharmacology (Berl). 1981; 73(3):246-51.
PMID: 6454158
DOI: 10.1007/BF00422411.
The validity of animal models of depression.
Willner P
Psychopharmacology (Berl). 1984; 83(1):1-16.
PMID: 6429692
DOI: 10.1007/BF00427414.
Comparison of mianserin with desipramine, maprotiline and phentolamine on cardiac presynaptic and vascular postsynaptic alpha-adrenoceptors and noradrenaline reuptake in pithed normotensive rats.
Cavero I, Gomeni R, Roach A
Br J Pharmacol. 1980; 68(2):321-32.
PMID: 6244040
PMC: 2043925.
DOI: 10.1111/j.1476-5381.1980.tb10421.x.
Lack of central 5-hydroxytryptamine influence on the anticonflict activity of diazepam.
Kilts C, Commissaris R, Cordon J, Rech R
Psychopharmacology (Berl). 1982; 78(2):156-64.
PMID: 6217479
DOI: 10.1007/BF00432255.
A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
Green A, Hall J, Rees A
Br J Pharmacol. 1981; 73(3):703-19.
PMID: 6166345
PMC: 2071691.
DOI: 10.1111/j.1476-5381.1981.tb16806.x.
The pharmacology of mianserin--an update.
Marshall R
Br J Clin Pharmacol. 1983; 15 Suppl 2:263S-268S.
PMID: 6130779
PMC: 1427877.
DOI: 10.1111/j.1365-2125.1983.tb05874.x.
Differences in presynaptic alpha-blockade, noradrenaline uptake inhibition, and potential antidepressant activity between (+)- and (-)mianserin.
Schoemaker H, Berendsen H, Stevens H, Nickolson V
Psychopharmacology (Berl). 1981; 74(2):137-42.
PMID: 6115445
DOI: 10.1007/BF00432680.
Kainic acid-induced wet dog shakes in rats. The relation to central neurotransmitters.
Kleinrok Z, Turski L
Naunyn Schmiedebergs Arch Pharmacol. 1980; 314(1):37-46.
PMID: 6108516
DOI: 10.1007/BF00498429.
Some effects of a new tetracyclic anti-depressant compound, Org GB 94, on the metabolism of monoamines in the rat brain.
Leonard B
Psychopharmacologia. 1974; 36(3):221-36.
PMID: 4846327
DOI: 10.1007/BF00421804.
Suppression of human growth hormone secretion by melatonin and cyproheptadine.
Smythe G, Lazarus L
J Clin Invest. 1974; 54(1):116-21.
PMID: 4600047
PMC: 301530.
DOI: 10.1172/JCI107732.
Proceedings: The effects of a new anti-depressant, ORG GB94, on amine uptake mechanisms.
Goodlet I, SUGRUE M
Br J Pharmacol. 1974; 52(3):431P.
PMID: 4458853
PMC: 1777011.
Peripheral serotonin antagonists: failure to antagonize serotonin in brain areas receiving a prominent serotonergic input.
Haigler H, Aghajanian G
J Neural Transm. 1974; 35(4):157-273.
PMID: 4373531
DOI: 10.1007/BF02205223.
Strain differences in response to drugs in the tail suspension test for antidepressant activity.
van der Heyden J, Molewijk E, Olivier B
Psychopharmacology (Berl). 1987; 92(1):127-30.
PMID: 3110823
DOI: 10.1007/BF00215493.
